FaizAnwerMD

PubMed

• Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study.
  Majid Jaberi-Douraki, Xuan Xu, Danai Dima, Sikander Ailawadhi, Faiz Anwer
  Blood Cancer Journal. 2024-12-20
• 2 citations
  Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy.
  Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel
  Blood Cancer Journal. 2024-12-05
• Rare case of wtTTR amyloidosis and MGUS in a patient with lung adenocarcinoma.
  Ahmad Safdar, Faiz Anwer
  BMJ Case Reports. 2024-12-02

Abstracts/Posters

• Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Infections Associated with CAR T Therapy for Treatment of Hematological Malignancies
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comparative Efficacy and Safety of Once Versus Twice Weekly Carfilzomib Based Therapies in Relapsed Refractory Multiple Myeloma- a Systematic Review
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• A Network Meta-Analysis of Clinical Trials Assessing Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Among Young Adults 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Efficacy and Toxicity Profile of Ibrutinib Based Regimens for Refractory Multiple Myeloma: A Systematic Review 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Relapse prevention with second generation tyrosine kinase inhibitors for Ph+ve acute leukemia after allogenic stem cell transplantation. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Join now to see all